International shipping of pharmaceuticals is an important element of the global health care system. Many countries rely upon imported medications to provide patient care for chronic illnesses, urgent medical situations, and rare diseases. Nevertheless, international shipping of pharmaceuticals carries numerous risks which can impact patient safety, regulatory compliance, and the quality of the medications themselves. By identifying these risks, businesses, healthcare providers and logistics companies will be better informed about how to protect themselves against these risks.
Regulatory compliance of international pharmaceuticals is considered one of the greatest risks associated with international shipping. Each country has specific laws and regulations regarding importing pharmaceutical products into that country. These laws and regulations frequently dictate how to obtain a license, the documentation required by customs, labeling requirements, and the types of health authority approval required.
In the event that your shipment does not comply with all applicable regulations, your shipment may be delayed, seized or destroyed by customs. A delayed or destroyed shipment could create financial loss for your company and create a lack of supply for critical medications. It is critical for anyone who ship pharmaceuticals internationally to remain abreast of the laws governing the importation of pharmaceuticals into other countries.
A number of medications, particularly vaccines, insulin and biologic medications, are temperature-sensitive during shipping. Due to the distance that many pharmaceuticals travel and the number of times that they are handled during shipping, there will most likely be a loss of effectiveness or a safety issue associated with medications that have not been maintained at their proper temperatures during shipment. Even small variations from the required temperature could lead to complete moisture loss and product degradation or contamination.
The International pharmaceutical distribution networks are at risk of counterfeit medication. Counterfeit or inferior medication can find their way into the supply chain at many points while moving through multiple nations in the course of international shipment.
Counterfeit medications pose a significant health threat to an individual consumer and compromise the reputational reputation of the drug company. To mitigate these risks, pharmaceutical companies will need to use secure packaging, tracking methods, and reliable logistics partners.
The method for transporting pharmaceuticals from one nation to another is also dependent upon the use of air and shipping or trucking. Interruptions to the flow of goods can occur as a direct result of climate impacts, international political issues, or Port congestion.
These types of interruptions in the flow of medication from country to country could lead to a shortage or expiration of or a missing date on a potential life-saving medication. Thus, the impact of a small delay could have potentially life-threatening implications.
Medications are sensitive, and therefore need to be packed in a special way to minimize exposure to moisture, light, physical damage, and contamination. An insufficient level of acceptable level of package protection or poor handling of the Medication Package while in transit may cause damage to the medication.
When a Medication Package’s packing is compromised, the medication contained within it may not be considered safe or effective anymore. The reduction of the risk of compromising the quality of medication is most efficiently accomplished through training on packing and handling procedures by properly trained personnel and establishing proper Packaging Standards.
Shipping documentation that is incomplete, inaccurate, and/or not compliant can create problems in getting through customs. Errors in invoices, certificates, or shipping labels can delay or reject the shipment.
Effective communication among the Manufacturer, Ship-from, Clearing Agent, and Consignee is essential for the successful delivery of medications.
Shipping medicines internationally is complicated and has many risks. Shipping medicines internationally has complexities due to the regulatory environment, temperature control, counterfeit medicines, logistical delays and the effect that all these factors have on patient outcomes. Establishing a partnership with a reliable logistics provider, complying with all international regulations, maintaining appropriate temperature and storage conditions and ensuring accurate shipping documentation are ways to minimize risks while providing safe and timely medications to patients.
Regulatory compliance risks refer to problems that occur when medicine shipments do not meet the legal and health regulations of importing or exporting countries. These risks include missing licenses, incorrect labeling, or lack of approval from health authorities.
Medicines are often delayed at customs due to incomplete documentation, incorrect declarations, or failure to comply with local pharmaceutical laws. Customs authorities may hold shipments for inspection to ensure safety and compliance.
Companies can reduce compliance risks by staying updated with international regulations, preparing accurate shipping documents, working with licensed logistics partners, and ensuring medicines meet labeling and packaging standards of the destination country.
If a shipment fails to meet regulatory requirements, it may be delayed, returned to the sender, seized, or destroyed by authorities. This can lead to financial loss and shortages of important medicines.